Clinical Trials Logo

Filter by:
NCT ID: NCT00306215 Completed - Crohn's Disease Clinical Trials

A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease

Start date: March 2006
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether CCX282-B is effective in treating patients with moderate to severe Crohn's Disease.

NCT ID: NCT00306202 Completed - Leukemia Clinical Trials

Study of Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia

Start date: March 31, 2006
Phase: Phase 1
Study type: Interventional

The purpose of this clinical research study was to establish a recommended phase 2 once daily (QD) dose of dasatinib and to assess the efficacy of the investigational drug for relapsed or refractory (resistant to previous treatment) leukemia in children and adolescents. The side effects that this oral investigational drug may have in children, and the levels of the drug in the blood, will be studied at different doses.

NCT ID: NCT00306163 Completed - Asthma Clinical Trials

Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101)

Start date: May 2006
Phase: Phase 3
Study type: Interventional

The aim of this study is to compare the responsiveness of lower airways in adult patients with stable asthma after treatment with ciclesonide and fluticasone propionate. Treatment medication will be administered as follows: ciclesonide will be inhaled once daily at one dose level, fluticasone propionate will be inhaled twice daily at one dose level. The study duration consists of a baseline period (5 weeks) and a treatment period (5 weeks). The study will provide further data on safety and tolerability of ciclesonide.

NCT ID: NCT00305084 Completed - Cancer Clinical Trials

Study of NGR-hTNF in Combination With Doxorubicin in Solid Tumors

Start date: February 28, 2006
Phase: Phase 1
Study type: Interventional

The main objective of the trial is to document the safety of the combination (escalation doses of NGR-hTNF, from 0.2 mcg/sqm to 1.6 mcg/sqm , with a fixed dose of doxorubicin, 75 mg/sqm). Safety will be established by clinical and laboratory assessment according to National Cancer Institute Common Toxicity Criteria (NCI-CTC ).

NCT ID: NCT00304577 Completed - Strabismus Clinical Trials

Bilateral Recession or Unilateral Recession-Resection as Surgery for Infantile Esotropia

Start date: January 1998
Phase: Phase 3
Study type: Observational

Infantile esotropia is corrected in most cases by bilateral recession of the medial rectus muscles (BR) or by unilateral recession of the medial rectus muscle and resection of the lateral rectus muscle (RR). We compared the outcome of these techniques in a randomized prospective study.

NCT ID: NCT00303602 Completed - Schizophrenia Clinical Trials

Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)

Start date: March 2006
Phase: Phase 4
Study type: Interventional

This study is testing if under the tongue olanzapine for schizophrenia, related psychosis, schizoaffective disorder or bipolar disorder will have less weight gain than olanzapine that is swallowed, in patients who are already gaining weight on olanzapine.

NCT ID: NCT00303381 Completed - Ulcerative Colitis Clinical Trials

Safety and Efficacy of Interferon-Beta-1a (Rebif®) for Treating Subjects With Acute Symptoms of Ulcerative Colitis

Start date: December 2001
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the safety and efficacy of interferon-beta-1a in subjects with active ulcerative colitis (UC).

NCT ID: NCT00301457 Completed - Breast Cancer Clinical Trials

Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer

DATA
Start date: June 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether 6 years adjuvant anastrozole will improve the disease free survival compared to 3 years adjuvant anastrozole in postmenopausal hormone sensitive breast cancer patients, subsequent to 2-3 years tamoxifen

NCT ID: NCT00301353 Completed - Osteoporosis Clinical Trials

Effects of Phytoestrogen-rich Diets on Bone Turnover in Postmenopausal Women

Start date: October 2002
Phase: N/A
Study type: Interventional

Osteoporosis is a major health problem. It was hypothesized that isoflavone-containing products may be a potential alternative to HRT for preventing bone loss during the menopausal transition. We investigated whether one-year consumption of isoflavone-enriched foods affected bone mineral density, bone metabolism and hormonal status in early postmenopausal women in a randomized double-blind, placebo controlled parallel multi-centre trial.

NCT ID: NCT00300131 Completed - Clinical trials for Coronary Artery Disease

ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical Investigation

ABSORB A
Start date: March 2006
Phase: Phase 3
Study type: Observational

Prospective, open-labeled First in Man Clinical Investigation enrolling patients with visually estimated nominal vessel diameter of 3.0 mm receiving a single 3.0 x 12 mm or 3.0 x 18 mm BVS EECSS containing 98 microgramme per cm² of surface area.